World's Best Scientists 2026 revealed!
Pamela J. Goodwin

Pamela J. Goodwin

D-Index & Metrics

Medicine

D-Index
86
Citations
31678
World Ranking
13982
National Ranking
580

Pamela J. Goodwin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pamela J. Goodwin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 284 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pamela J. Goodwin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pamela J. Goodwin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pamela J. Goodwin is affiliated with the University of Toronto in Canada and has a significant body of work primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research focuses notably on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, and Genetics.

They have contributed extensively to topics including Cancer Risks and Factors, Metabolism, Diabetes, and Cancer, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Nutritional Studies and Diet, Cancer, Lipids, and Metabolism, and Cancer-related Molecular Pathways.

Pamela J. Goodwin's recent papers include:

  • Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer (2022, JAMA)
  • The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer (2020, npj Breast Cancer)

Other frequent publication venues for their work are:

  • Journal of Clinical Oncology
  • JNCI Journal of the National Cancer Institute
  • npj Breast Cancer
  • Cancer Research
  • Clinical Cancer Research

They have collaborated frequently with several researchers, including:

  • Marguerite Ennis
  • Jennifer A. Ligibel
  • Dawn L. Hershman
  • Ana Elisa Lohmann
  • Bingshu E. Chen

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer

    Pamela J. Goodwin;Molyn Leszcz;Marguerite Ennis;Jan Koopmans

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;Maureen E. Trudeau

  • Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

    Andrea DeCensi;Matteo Puntoni;Pamela Goodwin;Massimiliano Cazzaniga

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Risk of Menopause During the First Year After Breast Cancer Diagnosis

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;Maureen Trudeau

  • Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

    M. Levine;J. Hirsh;A. Arnold;M. Gent

  • Prognostic factors in osteosarcoma : a critical review

    A M Davis;R S Bell;P J Goodwin

  • Understanding the benefit of metformin use in cancer treatment

    Ryan J O Dowling;Pamela J Goodwin;Vuk Stambolic

  • Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

    Ellen Warner;William Foulkes;Pamela Goodwin;Wendy Meschino

  • Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;Jarley Koo

  • Metformin in cancer: translational challenges

    Ryan J O Dowling;Saroj Niraula;Vuk Stambolic;Pamela J Goodwin

  • Adjuvant Treatment and Onset of Menopause Predict Weight Gain After Breast Cancer Diagnosis

    Pamela J. Goodwin;Marguerite Ennis;Kathleen I. Pritchard;David McCready

  • Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities

    Sao Jiralerspong;Pamela J Goodwin

  • Insulin and related factors in premenopausal breast cancer risk.

    M E Del Giudice;I G Fantus;I G Fantus;S Ezzat;G McKeown-Eyssen

  • Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction

    Marie E. Wood;Victor Vogel;Andrea Ng;Lewis E Foxhall

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

  • Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer—Taking Stock

    Pamela J Goodwin;Jeanne T Black;Louise J Bordeleau;Patricia A Ganz

  • Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

Frequent Co-Authors

Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
Vuk Stambolic
Vuk Stambolic University of Toronto
Irene L. Andrulis
Irene L. Andrulis University of Toronto
Timothy J. Whelan
Timothy J. Whelan McMaster University
Karen A. Gelmon
Karen A. Gelmon University of British Columbia
Patricia A. Ganz
Patricia A. Ganz University of California, Los Angeles
Dawn L. Hershman
Dawn L. Hershman Columbia University
John R. McLaughlin
John R. McLaughlin University of Toronto
Ingrid A. Mayer
Ingrid A. Mayer Vanderbilt University Medical Center
Esther M. John
Esther M. John Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not sure about medical school, there are several alternative online degrees and career pathways to consider. These programs offer flexibility, affordability, and solid job prospects in rapidly growing sectors.

A popular option is earning an online bachelor's in health information management. This degree prepares students for careers managing patient data and ensuring healthcare compliance.

For those interested in the administrative side of healthcare, a low cost medical coding and billing online program can lead to entry-level roles and quick employment, with minimal time spent in school.

If nursing is your passion, there are several most affordable nurse practitioner programs and affordable nursing programs online. These pathways provide training for both new students and those advancing in their nursing careers.

Each of these online options offers a unique approach to building a rewarding future in healthcare, no matter your background or goals.

Best Scientists Citing Pamela J. Goodwin

Trending Scientists